Martin Mynarek

Dr. Martin Mynarek is a Senior Physician and Medical Specialist in Pediatrics and Youth Medicine with a focus on Pediatric Hematology and Oncology at the University Medical Center Hamburg-Eppendorf (UKE). He is affiliated with the Department of Pediatric Hematology and Oncology within the Center for Obstetrics and Pediatrics under the Faculty of Medicine. His work centers on neuro-oncological research, particularly in pediatric brain tumors like medulloblastoma, ependymoma, and pineal parenchymal tumors. He contributes to international clinical trials, including the SIOP PNET5 MB trial, and emphasizes molecular stratification for improved patient outcomes.

Key research interests include risk stratification in medulloblastoma subgroups, molecular profiling of tumors, and the clinical impact of genetic alterations. He has led studies on treatment efficacy, radiation therapy outcomes, and long-term neurocognitive effects in survivors. His publications span over a decade, addressing topics such as liquid biopsy techniques, genetic syndromes in cancer, and multiomic approaches to diagnosis.

Dr. Mynarek collaborates extensively with institutions worldwide, contributing to consensus studies on tumor classification and treatment guidelines. His work bridges clinical practice and translational research, aiming to refine therapies and improve survival rates for pediatric cancer patients.